CLINICAL_TRIALS
research
· 2025-10-31
Clinical Trial Update: Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase) [Phase 4]
Summary
Post-trial access update for avalglucosidase alfa in participants with Pompe disease from a Phase 4 trial; the study is active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Glycogen Storage Disease Type II | Phase 4 | Status: ACTIVE_NOT_RECRUITING